| 2D Structure | |
| CID | 5362 |
| IUPAC Name | 4-[(4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methoxy]-4-oxobutanoic acid |
| InChI | InChI=1S/C24H26N2O6/c1-2-3-16-24(17-32-21(29)15-14-20(27)28)22(30)25(18-10-6-4-7-11-18)26(23(24)31)19-12-8-5-9-13-19/h4-13H,2-3,14-17H2,1H3,(H,27,28) |
| InChI Key | ONWXNHPOAGOMTG-UHFFFAOYSA-N |
| Canonical SMILES | None |
| Isomeric SMILES | None |
| Molecular Formula | C24H26N2O6 |
| Molecular Weight | 438.5 |
| synonyms | ['suxibuzone', '27470-51-5', 'Suxibuzona', 'Suxibuzonum', '4-Hydroxymethylbutazolidine hemisuccinate', '4-((4-Butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methoxy)-4-oxobutanoic acid', '4-[(4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methoxy]-4-oxobutanoic acid', 'DTXSID6021296', '86TDZ5WP2B', '4-Butyl-4-hydroxymethyl-1,2-diphenyl-3,5-pyrazolidinedione hydrogen succinate', 'NSC-757866', 'CHEBI:32173', 'DTXCID601296', 'RefChem:890070', '1,2-Diphenyl-4-n-butyl-4-hydroxymethyl-3,5-dioxopyrazolidine Hemisuccinate', '4-butyl-4-(beta-carboxypropionyloxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione', 'M02AA22', '248-477-6', 'Calibene', 'Flogos', 'Solurol', 'AE-17', '4-BUTYL-4-[HYDROXYMETHYL]-1,2-DIPHENYL-3,5-PYRAZOLIDINEDIONE HYDROGEN SUCCINATE [ESTER]', '4-Butyl-4-(hydroxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione hydrogen succinate (ester)', 'Succinic acid, monoester with 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione', 'NCGC00016799-01', 'Aflogan', 'Flamilon', 'Alfide', 'CAS-27470-51-5', '3,5-Pyrazolidinedione, 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-, hydrogen succinate (ester)', 'Suxibuzonum [INN-Latin]', 'Suxibuzona [INN-Spanish]', 'Butanedioic acid, mono((4-butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methyl) ester', 'Butanedioic acid, mono[(4-butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methyl] ester', 'AE 17', 'SR-01000841241', 'EINECS 248-477-6', 'UNII-86TDZ5WP2B', 'BRN 0904563', 'Suxibuzon', 'Suxibuzone [INN:BAN:JAN]', 'Suxibuzone CRS', 'Suxibuzone; 4-[(4-Butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methoxy]-4-oxobutanoic acid', 'Prestwick_113', 'MFCD00079562', 'Suxibuzone (Standard)', 'Spectrum_000321', 'Suxibuzone (JAN/INN)', 'SUXIBUZONE [INN]', 'SUXIBUZONE [JAN]', 'Prestwick0_000658', 'Prestwick1_000658', 'Prestwick2_000658', 'Prestwick3_000658', 'Spectrum2_000966', 'Spectrum3_000664', 'Spectrum4_000433', 'Spectrum5_001113', 'Epitope ID:124941', '4-Butyl-4-(beta-carboxypropionyl-oxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione', 'SUXIBUZONE [MART.]', '3-((4-Butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methoxycarbonyl)propionsaeure', 'SUXIBUZONE [WHO-DD]', 'SCHEMBL25810', 'BSPBio_000695', 'BSPBio_002327', 'KBioGR_000786', 'KBioSS_000801', 'MLS002153938', 'DivK1c_000171', 'SPECTRUM1501157', 'SPBio_000971', 'SPBio_002616', 'BPBio1_000765', 'orb1710722', 'CHEMBL1414320', 'SUXIBUZONE [EP IMPURITY]', 'HMS500I13', 'HY-B1079R', 'KBio1_000171', 'KBio2_000801', 'KBio2_003369', 'KBio2_005937', 'KBio3_001547', 'BRD5826', 'SUXIBUZONE [EP MONOGRAPH]', 'NINDS_000171', 'HMS1570C17', 'HMS1923I17', 'HMS2097C17', 'HMS2232E17', 'HMS3371A12', 'HMS3714C17', 'HMS5083M15', 'Pharmakon1600-01501157', 'BRD-5826', 'HY-B1079', 'Tox21_110615', 'Tox21_202352', 'Tox21_302778', 'CCG-40180', 'NSC757866', 'AKOS024374988', 'Tox21_110615_1', 'CS-4635', 'DB13232', 'NSC 757866', '4-{[(4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methyl]oxy}-4-oxobutanoic acid', 'IDI1_000171', 'NCGC00016799-02', 'NCGC00016799-03', 'NCGC00016799-04', 'NCGC00016799-05', 'NCGC00016799-06', 'NCGC00016799-08', 'NCGC00095261-01', 'NCGC00095261-02', 'NCGC00095261-03', 'NCGC00095261-04', 'NCGC00256470-01', 'NCGC00259901-01', 'MS-27855', 'SMR001233279', 'SBI-0051667.P002', 'DB-047228', 'AB00052229', 'NS00008152', 'ST51015119', 'D01289', 'F85232', 'AB00052229_08', 'AB00052229_09', 'Q7650623', 'SR-01000841241-2', 'SR-01000841241-3', 'BRD-K78815826-001-05-4', 'BRD-K78815826-001-08-8', 'BRD-K78815826-001-13-8', 'BRD-K78815826-001-14-6', 'Suxibuzone, European Pharmacopoeia (EP) Reference Standard', '4-[(4-Butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methoxy]-4-oxobutanoic acid', '4-[(4-butyl-3,5-dioxo-1,2-diphenyl-pyrazolidin-4-yl)methoxy]-4-oxo-butanoic acid', '4-Butyl-4-(.beta.-carboxypropionyl-oxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione', '3-{[(4-butyl-3,5-dioxo-1,2-diphenyl-1,2-diazolidin-4-yl)methyl]oxycarbonyl}pro panoic acid'] |
From Pubchem